Medium-chain acyl-CoA dehydrogenase deficiency;
|Description||Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is an autosomal recessive disorder, caused by mutations in the ACADM gene. It is the most commonly recognized defect of mitochondrial beta-oxidation and is potentially fatal. The clinical manifestations are diverse, but usually they include fasting induced non-ketotic hypoglycemia with lethargy which may develop into coma.|
|Category||Inherited metabolic disease; Mitochondrial disease|
|Gene||ACADM [HSA:34] [KO:K00249]|
|Marker||Urinary excretion of C6-C10 dicarboxylic acids, acylglycine, and acylcarnitine.|
|Other DBs||ICD-10: E71.3
Andresen BS, Bross P, Udvari S, Kirk J, Gray G, Kmoch S, Chamoles N, Knudsen I, Winter V, Wilcken B, Yokota I, Hart K, Packman S, Harpey JP, Saudubray JM, Hale DE, Bolund L, Kolvraa S, Gregersen N
The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype?
Hum Mol Genet 6:695-707 (1997)
Leal J, Ades AE, Wordsworth S, Dezateux C
Regional differences in the frequency of the c.985A>G ACADM mutation: findings from a meta-regression of genotyping and screening studies.
Clin Genet 85:253-9 (2014)
Lee PJ, Harrison EL, Jones MG, Jones S, Leonard JV, Chalmers RA
L-carnitine and exercise tolerance in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency: a pilot study.
J Inherit Metab Dis 28:141-52 (2005)